Plain-English translation of NCT06607705 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing how well the iStent Inject W — a tiny implant placed inside the eye — helps lower eye pressure in people with glaucoma who haven't had eye surgery before. Researchers will use a special contact lens sensor to track eye pressure changes over 24 hours, both before surgery and after the implant is placed, to understand exactly how this treatment works.
Current ways of measuring eye pressure only capture readings at specific moments in time, which may miss important changes that happen throughout the day. This study exists to get a fuller picture of how the medication or eye drops and this new implant treatment work together to control eye pressure continuously.
You likely qualify if…
You likely don't qualify if…
You will wear a special pressure-monitoring contact lens for 24 hours before your scheduled glaucoma surgery — during this time, you'll go about your normal activities at home and work while keeping a log of when you take your eye drops and when you sleep. One month after your iStent Inject W surgery, the research team will track your eye pressure using the same contact lens sensor to see how the implant has changed your pressure patterns. The entire study lasts about 12 months, with visits at the hospital clinic for the contact lens placement and removal, along with standard eye exams.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain